/Companies

Calyxt

NASDAQ: CBUS

New Brighton, US · Delaware corporation

Find your way into Calyxt

Sign up to see every warm intro you have to Calyxt

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Calyxt team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cibus develops gene-edited plant traits for major agricultural crops using its proprietary Rapid Trait Development System, which it licenses to seed companies for royalties. The company focuses primarily on productivity traits such as herbicide tolerance and disease resistance for rice, canola, and soybean, targeting markets in the Americas, Asia, and other regions where regulatory environments permit gene-edited crop commercialization.

Founders & leadership

DVDaniel Voytas
Daniel VoytasFounder
FA
Federico A. TripodiExecutive
JB
Joseph B. SaluriExecutive
PB
Peter BeethamInterim Chief Executive Officer, President and Chief Operating Officer, and Director
GG
Greg GocalChief Scientific Officer and Executive Vice President
C(
Cornelis (Carlo) BroosChief Financial Officer
JS
Jason StokesChief Administrative Officer, General Counsel and Corporate Secretary
FZ
Feng ZhangNamed on SEC filing
GM
Glenn M. BowersNamed on SEC filing
MS
Manoj SahooNamed on SEC filing
MA
Michel ArbadjiNamed on SEC filing
BW
Bryan W.J. CorkalNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$47.5M disclosed across 1 round · 2017

▶$47.5MraisedJun 2017 · 48 investors · Agriculture
Rule 506(b)
Officers, directors & promoters on the filing
  • Feng ZhangExecutive Officer
  • Glenn M. BowersExecutive Officer
  • Daniel VoytasExecutive Officer
  • Manoj SahooExecutive Officer
  • Federico A. TripodiExecutive Officer
  • Michel ArbadjiExecutive Officer
  • Andre ChoulikaDirector
  • Joseph B. SaluriExecutive Officer
  • Bryan W.J. CorkalExecutive Officer
Amount sold
$47.5M
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$212.8Mvaluation at IPOJul 2017 · $8.00/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Frequently asked questions

What does Calyxt do?
Cibus develops gene-edited plant traits for major agricultural crops using its proprietary Rapid Trait Development System, which it licenses to seed companies for royalties. The company focuses primarily on productivity traits such as herbicide tolerance and disease resistance for rice, canola, and soybean, targeting markets in the Americas, Asia, and other regions where regulatory environments permit gene-edited crop commercialization.
Who founded Calyxt?
Calyxt was founded by Daniel Voytas.
How much funding has Calyxt raised?
Calyxt has disclosed $47.5M raised across 1 round.
Where is Calyxt headquartered?
Calyxt is headquartered in New Brighton, US.